Endothelin levels in experimental diabetes combined with cardiac hypertrophy

被引:0
|
作者
Skoumal, R
Seres, L
Soós, P
Balogh, E
Kovàts, T
Rysa, J
Ruskoaho, H
Tóth, M
Horkay, F
机构
[1] Semmelweis Univ, Dept Internal Med 1, H-1083 Budapest, Hungary
[2] Gyorgy Gottsegen Natl Inst Cardiol, Budapest, Hungary
[3] Oulu Univ, Dept Pharmacol & Toxicol, SF-90220 Oulu, Finland
[4] Hungarian Acad Sci, Mol Genet Res Grp, H-1051 Budapest, Hungary
关键词
endothelin; cardiac hypertrophy; diabetes;
D O I
10.1097/01.fjc.0000166240.41830.04
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Diabetes mellitus is associated with endothelial and cardiac dysfunction, and endothelin has been suggested to alter cardiac function by being a positive inotropic agent, modulating the Frank-Starling response, contracting the coronary arteries and inducing tissue proliferation. We investigated endothelin levels in diabetic and in healthy dogs, 1 and 3 days after placing arteriovenous shunts (8 weeks after diabetes induction) in the femoral regions. Right and left ventricular weight/body weight ratios and N-terminal-atrial natriuretic peptide were increased in shunted animals (P < 0.05). Plasma endothelin levels were comparable in healthy and diabetic dogs. Shunted circulation did not change systemic endothelin levels in healthy dogs but reduced endothelin levels in diabetic dogs. The functional significance of altered endothelin responses to acute hemodynamic burden in experimental diabetes needs further investigation.
引用
收藏
页码:S195 / S197
页数:3
相关论文
共 50 条
  • [31] CARDIAC ENERGY STORES AND CREATINE IN EXPERIMENTAL CARDIAC-HYPERTROPHY
    REILLY, PJ
    COOKSEY, JD
    PROCEEDINGS OF THE SOCIETY FOR EXPERIMENTAL BIOLOGY AND MEDICINE, 1979, 161 (02): : 193 - 198
  • [32] Development of an Experimental Model of Cardiac Failure Combined with Type I Diabetes Mellitus
    S. A. Afanasiev
    D. S. Kondratyeva
    S. V. Popov
    Bulletin of Experimental Biology and Medicine, 2012, 153 : 530 - 532
  • [33] Development of an Experimental Model of Cardiac Failure Combined with Type I Diabetes Mellitus
    Afanasiev, S. A.
    Kondratyeva, D. S.
    Popov, S. V.
    BULLETIN OF EXPERIMENTAL BIOLOGY AND MEDICINE, 2012, 153 (04) : 530 - 532
  • [34] Neonatal cardiac myocytes: Experimental systems for study of cardiac hypertrophy
    Morgan, HE
    Beinlich, CJ
    DEVELOPING HEART, 1997, : 325 - 336
  • [35] Experimental concentric and eccentric cardiac hypertrophy in rats
    Rytand, DA
    Dock, W
    ARCHIVES OF INTERNAL MEDICINE, 1935, 56 (03) : 511 - 520
  • [36] MYOCARDIAL RNA SYNTHESIS IN EXPERIMENTAL CARDIAC HYPERTROPHY
    KOIDE, T
    GROVE, DD
    CIRCULATION, 1967, 36 (4S2) : I163 - &
  • [37] PATHOGENESIS OF CARDIAC-HYPERTROPHY IN EXPERIMENTAL HYPERTENSION
    KOLAROVA, R
    AGRESSOLOGIE, 1975, 16 : 55 - 59
  • [38] Creatine content of the heart in experimental cardiac hypertrophy
    Cowan, DW
    PROCEEDINGS OF THE SOCIETY FOR EXPERIMENTAL BIOLOGY AND MEDICINE, 1934, 31 (04): : 417 - 418
  • [39] DIGITOXIN TREATMENT AND EXPERIMENTAL CARDIAC HYPERTROPHY IN RAT
    TURTO, H
    LINDY, S
    CARDIOVASCULAR RESEARCH, 1973, 7 (04) : 482 - 489
  • [40] Neuraminidase 1 is a driver of experimental cardiac hypertrophy
    Chen, Qian-Qian
    Ma, Gaoxiang
    Liu, Jin-Feng
    Cai, Yuan-Yuan
    Zhang, Jun-Yuan
    Wei, Ting-Ting
    Pan, An
    Jiang, Shujun
    Xiao, Yibei
    Xiao, Pingxi
    Song, Jiangping
    Li, Ping
    Zhang, Lei
    Qi, Lian-Wen
    EUROPEAN HEART JOURNAL, 2021, 42 (36) : 3770 - +